Drugs / MT-2301
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02140047 | Apr 2014 → Jan 2015 | haemophilus infectious disease | Tanabe Pharma Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MT-2301 | “Exploratory Clinical Study of MT-2301” NCT02140047 ↗ |